(1S,4E,7S,9R)-4-[(1H-imidazol-4-yl)methylidene]-9-(2-methylbut-3-en-2-yl)-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-10,12,14-triene-3,6-dione

Compound number
MolPort-042-675-291
CAS number
68628-81-9
IUPAC
(1S,4E,7S,9R)-4-[(1H-imidazol-4-yl)methylidene]-9-(2-methylbut-3-en-2-yl)-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-10,12,14-triene-3,6-dione
IUPAC traditional
(1S,4E,7S,9R)-4-(1H-imidazol-4-ylmethylidene)-9-(2-methylbut-3-en-2-yl)-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-10,12,14-triene-3,6-dione
SMILES
CC(C)(C=C)[C@@]12C[C@@H]3N([C@@H]1Nc1ccccc21)C(=O)\C(NC3=O)=C/c1c[nH]cn1 |r|
InChI key
SPWSUFUPTSJWNG-JJUKSXGLSA-N
Molecular formula
Molecular weight
389.459
Solubility
not available

Marketplace Offers

AnalytiCon Discovery, GmbH

Direct S&H to USA 145.00 USD Direct S&H to World: 175.00 USD
Catalog
Screening compound
Ships out
15 business days
Purity
>85
Last updated
yesterday
In warehouse
3.00 mg

Supplier Catalogue Data

Pack size Ships out Price Quantity
1 mg July 28, 2022 474.72 USD
Add to Cart Buy
2 mg July 28, 2022 588.24 USD
Add to Cart Buy
3 mg July 28, 2022 700.47 USD
Add to Cart Buy

Get your compounds in the right format

MolPort Reweighting and Reformatting Services

More Information

Compound identifiers

Compound number
MolPort-042-675-291
CAS number
68628-81-9

Names, Synonyms and 3rd Party Identifiers

InChI

InChI
1/C22H23N5O2/c1-4-21(2,3)22-10-17-18(28)25-16(9-13-11-23-12-24-13)19(29)27(17)20(22)26-15-8-6-5-7-14(15)22/h4-9,11-12,17,20,26H,1,10H2,2-3H3,(H,23,24)(H,25,28)/b16-9+/t17-,20-,22+/m0/s1
InChI key
SPWSUFUPTSJWNG-JJUKSXGLSA-N

Formula

Molecular formula
C22H23N5O2
Molecular weight
389.459

MolPort Guarantee

When you purchase products through the MolPort website from any seller other than MolPort itself, you will be protected by the MolPort Guarantee. If you purchase products from MolPort itself, this MolPort Guarantee will not apply, and your remedies will be governed by the MolPort Terms of Sale and Supply.

We use cookies to improve your experience on our websites and for advertising. By clicking "Accept All", you consent to our use of cookies. Learn more

Feedback